Strategic partnerships Idoven has a history of high-profile collaborations with Abbott, AstraZeneca, Al Jalila Foundation, and EIC/Horizon 2020 funding, signaling openness to co-development and enterprise-scale pilots. Leverage these relationships to propose expanded AI-driven ECG analytics deployments and joint clinical studies with pharmaceutical and medical device partners.

PaMD readiness The Platform as a Medical Device certification (EU MDR Class IIa) and clinical-grade accuracy position Idoven for regulated deployments across hospitals and clinics. Target health systems seeking certified AI diagnostics to streamline ECG interpretation, risk stratification, and workflow integration.

Willem ecosystem Willem AI processes ECGs from diverse devices and underpins biomarker development, prognosis, and drug cardiac safety monitoring. Sell to hospitals and CROs needing scalable, device-agnostic AI models and access to large, annotated ECG databases for research and regulatory submissions.

Global expansion Awards and international funding along with Madrid base indicate growth trajectory and potential for regional scaling in Europe and the US. Propose enterprise licenses, managed services, and regional implementation support for global health networks and multinational pharmaceutical collaborations.

Data and analytics stack Technologies include cloud, BigQuery, Grafana, Power BI, and GitLab suggesting mature data infrastructure. Offer value through integrated analytics dashboards for clinical outcomes, payer-ready ROI analyses, and data-driven monitoring of AI performance in real-world use cases.